Literature DB >> 10372077

Short-latency visual stabilization mechanisms that help to compensate for translational disturbances of gaze.

F A Miles1.   

Abstract

Recent studies in primates have revealed short-latency visual tracking mechanisms that help to stabilize the eyes during translational disturbances of the observer, and so operate as backups to otolith-mediated vestibulo-ocular reflexes. One such mechanism generates version eye movements to help stabilize gaze when the moving observer looks off to one side, utilizing binocular disparity to help single out the images in the plane of fixation (ocular following). Two others generate vergence eye movements to help maintain binocular alignment on objects that lie ahead: one responds to the radial patterns of optic flow (radial-flow vergence) and the other to the changes in binocular parallax (disparity vergence). Accumulating evidence suggests that, despite their short latency, all are mediated by the medial superior temporal area of cortex.

Mesh:

Year:  1999        PMID: 10372077     DOI: 10.1111/j.1749-6632.1999.tb09190.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Rotational and translational optokinetic nystagmus have different kinematics.

Authors:  Jing Tian; David S Zee; Mark F Walker
Journal:  Vision Res       Date:  2007-02-22       Impact factor: 1.886

2.  Visually mediated eye movements regulate the capture of optic flow in self-motion perception.

Authors:  Juno Kim; Stephen Palmisano
Journal:  Exp Brain Res       Date:  2009-12-30       Impact factor: 1.972

3.  The cerebellar nodulus/uvula integrates otolith signals for the translational vestibulo-ocular reflex.

Authors:  Mark F Walker; Jing Tian; Xiaoyan Shan; Rafael J Tamargo; Howard Ying; David S Zee
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

4.  The gait disorder in downbeat nystagmus syndrome.

Authors:  Roman Schniepp; Max Wuehr; Sabrina Huth; Cauchy Pradhan; Cornelia Schlick; Thomas Brandt; Klaus Jahn
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.